Japanese encephalitis: A tale of inflammation and degeneration in the central nervous system

Neuroinflammation and Neurodegeneration

Volumn , Issue , 2014, Pages 309-335

  Dutta, Kallol ^a   Basu, Anirban ^b  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

Flavivirus; Inflammation; Japanese encephalitis; Neurodegeneration; Neuropsychiatric sequelae

Indexed keywords

EID: 84929852738     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1071-7_15     Document Type: Chapter

References (204)

1. Hiroyama T. Epidemiology of Japanese encephalitis (in Japanese). Saishin-Igaku. 1962;17: 1272-80.
2. Hayashi M. Ubertragung des virus von encephalitis epidemica auf Affen. Proc Imp Acad Tokyo. 1934;10:41-4.
3. Rosen L. The natural history of Japanese encephalitis virus. Annu Rev Microbiol. 1986;40:395-414.
4. Lu G, Gong P. Crystal Structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface. PLoS Pathog. 2013;9(8):e1003549.
5. Chen CJ, et al. RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA. J Virol. 1997;71(5):3466-73.
6. Edward Z, Takegami T. Localization and functions of Japanese encephalitis virus nonstructural proteins NS3 and NS5 for viral RNA synthesis in the infected cells. Microbiol Immunol. 1993;37(3):239-43.
7. Kuo MD, et al. Characterization of the NTPase activity of Japanese encephalitis virus NS3 protein. J Gen Virol. 1996;77(Pt 9):2077-84.
8. Jan LR, et al. Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases. J Gen Virol. 1995;76(Pt 3):573-80.
9. Chang YS, et al. Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. J Virol. 1999;73(8):6257-64.
10. Katoh H, et al. Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA. J Virol. 2011;85(21):10976-88.
11. Li C, et al. The DEAD-box RNA helicase DDX5 acts as a positive regulator of Japanese encephalitis virus replication by binding to viral 3' UTR. Antiviral Res. 2013;100(2): 487-99.
12. Li C, et al. Cellular DDX3 regulates Japanese encephalitis virus replication by interacting with viral un-translated regions. Virology. 2014;449:70-81.
13. Ye J, et al. Heat shock protein 70 is associated with replicase complex of Japanese encephalitis virus and positively regulates viral genome replication. PLoS One. 2013;8(9):e75188.
14. Tien CF, et al. Inhibition of aldolase A blocks biogenesis of ATP and attenuates Japanese encephalitis virus production. Biochem Biophys Res Commun. 2014;443(2):464-9.
15. Gould EA. Evolution of the Japanese encephalitis serocomplex viruses. Curr Top Microbiol Immunol. 2002;267:391-404.
16. Solomon T, et al. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol. 2003;77(5):3091-8.
17. Mohammed MA, et al. Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missingfifth genotype. Infect Genet Evol. 2011;11(5):855-62.
18. Schuh AJ, et al. Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951. J Gen Virol. 2010;91(Pt 1):95-102.
19. Solomon T, et al. Japanese encephalitis. J Neurol Neurosurg Psychiatry. 2000;68(4): 405-15.
20. Huong VT, Ha DQ, Deubel V. Genetic study of Japanese encephalitis viruses from Vietnam. Am J Trop Med Hyg. 1993;49(5):538-44.
21. Fulmali PV, et al. Introduction of Japanese encephalitis virus genotype I, India. Emerg Infect Dis. 2011;17(2):319-21.
22. Sarkar A, et al. Molecular evidence for the occurrence of Japanese encephalitis virus genotype I and III infection associated with acute encephalitis in patients of West Bengal, India, 2010. Virol J. 2012;9:271.
23. Schuh AJ, et al. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J Virol. 2014;88:4522-32.
24. Scherer WF, et al. Ecologic studies of Japanese encephalitis virus in Japan. III. Mosquito factors. Zootropism and verticalflight of Culex tritaeniorhynchus with observations on variations in collections from animal-baited traps in different habitats. Am J Trop Med Hyg. 1959;8:665-77.
25. Scherer WF, Buescher EL, McClure HE. Ecologic studies of Japanese encephalitis virus in Japan. V. Avian factors. Am J Trop Med Hyg. 1959;8:689-97.
26. Scherer WF, et al. Ecologic studies of Japanese encephalitis virus in Japan. VIII. Survey for infection of wild rodents. Am J Trop Med Hyg. 1959;8:716-8.
27. Scherer WF, et al. Ecologic studies of Japanese encephalitis virus in Japan. VII. Human infection. Am J Trop Med Hyg. 1959;8:707-15.
28. Scherer WF, et al. Ecologic studies of Japanese encephalitis virus in Japan. VI. Swine infection. Am J Trop Med Hyg. 1959;8:698-706.
29. Buescher EL, Scherer WF. Ecologic studies of Japanese encephalitis virus in Japan. IX. Epidemiologic correlations and conclusions. Am J Trop Med Hyg. 1959;8:719-22.
30. Buescher EL, et al. Ecologic studies of Japanese encephalitis virus in Japan. IV. Avian infection. Am J Trop Med Hyg. 1959;8:678-88.
31. Buescher EL, et al. Ecologic studies of Japanese encephalitis virus in Japan. II. Mosquito infection. Am J Trop Med Hyg. 1959;8:651-64.
32. Takahashi M, Suzuki K. Japanese encephalitis virus in mosquito salivary glands. Am J Trop Med Hyg. 1979;28(1):122-35.
33. Solomon T. Recent advances in Japanese encephalitis. J Neurovirol. 2003;9(2):274-83.
34. Hoke CH, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med. 1988;319(10):608-14.
35. Hancock J, Kushlan J. The herons handbook. New York, NY: Harper and Row; 1984.
36. Ghosh D, Basu A. Japanese encephalitis-A pathological and clinical perspective. PLoS Negl Trop Dis. 2009;3(9):e437.
37. Chan YC, Loh TF. Isolation of Japanese encephalitis virus from the blood of a child in Singapore. Am J Trop Med Hyg. 1966;15(4):567-72.
38. Igarashi A, et al. Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinalfluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol. 1994;38(10):827-30.
39. Grascenkov NI. Japanese encephalitis in the USSR. Bull World Health Organ. 1964;30:161-72.
40. Hanna JN, et al. Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust. 1999;170(11):533-6.
41. Hanna JN, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust. 1996;165(5):256-60.
42. Bai L, Morton LC, Liu Q. Climate change and mosquito-borne diseases in China: A review. Global Health. 2013;9(1):10.
43. Ravanini P, et al. Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy. Euro Surveill. 2012;17(28).
44. Garcia-Bocanegra I, et al. Serosurvey of West nile virus and otherflaviviruses of the Japanese encephalitis antigenic complex in birds from Andalusia, southern Spain. Vector Borne Zoonotic Dis. 2011;11(8):1107-13.
45. Platonov A, et al. Does the Japanese encephalitis virus (JEV) represent a threat for human health in Europe? Detection of JEV RNA sequences in birds collected in Italy. Euro Surveill. 2012;17(32) pii: 20241.
46. Doti P, et al. A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013. Euro Surveill. 2013;18(35):20573.
47. Lagarde S, et al. Japanese encephalitis in a French traveler to Nepal. J Neurovirol. 2014; 20(1):99-102.
48. Tappe D, et al. Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia. J Clin Virol. 2012;54(3):282-5.
49. Zimmerman HM. The pathology of Japanese B encephalitis. Am J Pathol. 1946;22:965-91.
50. Sabin AB, Schlesinger RW, et al. Japanese B encephalitis in American soldiers in Korea. Am J Hyg. 1947;46(3):356-75.
51. Nemeth N, et al. North American birds as potential amplifying hosts of Japanese encephalitis virus. Am J Trop Med Hyg. 2012;87(4):760-7.
52. Campbell GL, et al. Estimated global incidence of Japanese encephalitis: A systematic review. Bull World Health Organ. 2011;89(10):766-74. 774A-774E.
53. Erlanger TE, et al. Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009;15(1):1-7.
54. Chaturvedi UC, et al. Transplacental infection with Japanese encephalitis virus. J Infect Dis. 1980;141(6):712-5.
55. Mathur A, Arora KL, Chaturvedi UC. Congenital infection of mice with Japanese encephalitis virus. Infect Immun. 1981;34(1):26-9.
56. Shiraki H. Japanese encephalitis. In: Debre R, Celers J, editors. Clinical virology. Philadelphia, PA: W.B. Saunders; 1970. p. 155-75.
57. Myint KS, et al. Unravelling the neuropathogenesis of Japanese encephalitis. Trans R Soc Trop Med Hyg. 2007;101(10):955-6.
58. Johnston LJ, Halliday GM, King NJ. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J Invest Dermatol. 2000;114(3):560-8.
59. Diamond MS. Evasion of innate and adaptive immunity byflaviviruses. Immunol Cell Biol. 2003;81(3):196-206.
60. Dutta K, et al. Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis. J Neuroimmune Pharmacol. 2010;5(4): 553-65.
61. Mukherji AK, Biswas SK. Histopathological studies of brains (and other viscera) from cases of JE virus encephalitis during 1973 epidemic at Bankura. Indian J Med Res. 1976;64(8): 1143-9.
62. Miyake M. The pathology of Japanese encephalitis. A review. Bull World Health Organ. 1964;30:153-60.
63. Myint KS, et al. Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. Am J Trop Med Hyg. 1999; 60(3):338-42.
64. Sapkal GN, et al. Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection. Am J Trop Med Hyg. 2007;77(6):1139-45.
65. Johnson RT, et al. Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol. 1985;18(5):567-73.
66. Dutta K, et al. Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection. Immunobiology. 2010; 215(11):884-93.
67. Aleyas AG, et al. Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and-independent pathways. J Immunol. 2009;183(4):2462-74.
68. Chen ST, et al. CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality. PLoS Pathog. 2012;8(4):e1002655.
69. Mishra MK, et al. Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent. Neurochem Int. 2009;55(8):717-23.
70. Lai CY, et al. Endothelial Japanese encephalitis virus infection enhances migration and adhesion of leukocytes to brain microvascular endothelia via MEK-dependent expression of ICAM1 and the CINC and RANTES chemokines. J Neurochem. 2012;123(2):250-61.
71. Mathur A, Khanna N, Chaturvedi UC. Breakdown of blood-brain barrier by virus-induced cytokine during Japanese encephalitis virus infection. Int J Exp Pathol. 1992;73(5):603-11.
72. Ravi V, et al. Correlation of tumor necrosis factor levels in the serum and cerebrospinalfluid with clinical outcome in Japanese encephalitis patients. J Med Virol. 1997;51(2):132-6.
73. Singh A, Kulshreshtha R, Mathur A. Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection. J Med Microbiol. 2000;49(7):607-12.
74. Zhu YZ, et al. Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway. J Virol. 2012;86(24):13407-22.
75. Kalia M, et al. Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J Virol. 2013;87(1):148-62.
76. Nawa M, et al. Interference in Japanese encephalitis virus infection of vero cells by a cationic amphiphilic drug, chlorpromazine. J Gen Virol. 2003;84(Pt 7):1737-41.
77. Das S, Ravi V, Desai A. Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. Virus Res. 2011;160(1-2):404-8.
78. Das S, Chakraborty S, Basu A. Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells. J Neurochem. 2010;115(2):537-49.
79. Zhu YZ, et al. Association of heat-shock protein 70 with lipid rafts is required for Japanese encephalitis virus infection in Huh7 cells. J Gen Virol. 2012;93(Pt 1):61-71.
80. Thongtan T, et al. Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells. J Med Virol. 2012;84(4):615-23.
81. Swarup V, et al. Tumor necrosis factor receptor-1-induced neuronal death by TRADD contributes to the pathogenesis of Japanese encephalitis. J Neurochem. 2007;103(2):771-83.
82. Swarup V, et al. Tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis. Neurochem Int. 2008;52(7):1310-21.
83. Yiang GT, et al. The NS3 protease and helicase domains of Japanese encephalitis virus trigger cell death via caspase dependent and independent pathways. Mol Med Rep. 2013;7(3): 826-30.
84. Chien HL, Liao CL, Lin YL. FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication. J Virol. 2011; 85(10):4698-706.
85. Nazmi A, Dutta K, Basu A. RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection. PLoS One. 2011;6(6):e21761.
86. Nazmi A, et al. STING mediates neuronal innate immune response following Japanese encephalitis virus infection. Sci Rep. 2012;2:347.
87. Jin R, et al. Japanese encephalitis virus activates autophagy as a viral immune evasion strategy. PLoS One. 2013;8(1):e52909.
88. Ghoshal A, et al. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia. 2007;55(5):483-96.
89. Chen CJ, et al. Astrocytic alteration induced by Japanese encephalitis virus infection. Neuroreport. 2000;11(9):1933-7.
90. Mishra MK, et al. Neuroprotection conferred by astrocytes is insufficient to protect animals from succumbing to Japanese encephalitis. Neurochem Int. 2007;50(5):764-73.
91. Thounaojam MC, et al. MicroRNA-155 regulates japanese encephalitis virus induced inflammatory response by targeting src homology 2-containing inositol phosphatase-1 (SHIP1). J Virol. 2014;88:4798-810.
92. Thounaojam MC, et al. MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. J Neurochem. 2013;129:143-54.
93. Jeurissen A, Strauven T. A case of aseptic meningitis due to Japanese encephalitis virus in a traveller returning from the Philippines. Acta Neurol Belg. 2011;111(2):143-5.
94. Hosokawa T, et al. Case report of aseptic meningitis due to Japanese encephalitis virus. Rinsho Shinkeigaku. 2007;47(2-3):109-11.
95. Kuwayama M, et al. Japanese encephalitis virus in meningitis patients, Japan. Emerg Infect Dis. 2005;11(3):471-3.
96. Rudolph KE, et al. Incubation periods of mosquito-borne viral infections: A systematic review. Am J Trop Med Hyg. 2014;90(5):882-91.
97. Simpson TW, Meiklejohn G. Sequelae of Japanese B encephalitis. Am J Trop Med Hyg. 1947;27(6):727-31.
98. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol. 2002;267:171-94.
99. Gourie-Devi M, Ravi V, Shankar SK. Japanese encephalitis: an overview. In: Rose FC, editor. Recent advances in tropical neurology. Amsterdam: Elsevier Sciences B.V.; 1995. p. 217-35.
100. Kakoti G, et al. Clinical profile and outcome of Japanese encephalitis in children admitted with acute encephalitis syndrome. Biomed Res Int. 2013;2013:152656.
101. Desai A, et al. Detection of immune complexes in the CSF of Japanese encephalitis patients: correlation offindings with outcome. Intervirology. 1994;37(6):352-5.
102. Kumar R, et al. Clinical features & prognostic indicators of Japanese encephalitis in children in Lucknow (India). Indian J Med Res. 1990;91:321-7.
103. Solomon T, et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002;125(Pt 5):1084-93.
104. Desai A, et al. Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol. 1995;89(4):368-73.
105. Carroll E, Sanchez-Ramos J. Hyperkinetic movement disorders associated with HIV and other viral infections. Handb Clin Neurol. 2011;100:323-34.
106. Ogata A, et al. A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol. 1997;3(2):141-7.
107. Misra UK, Kalita J. Movement disorders in Japanese encephalitis. J Neurol. 1997;244(5): 299-303.
108. Kalita J, Misra UK, Pradhan PK. Oromandibular dystonia in encephalitis. J Neurol Sci. 2011;304(1-2):107-10.
109. Kumar A. Isolated involvement of substantia nigra in Japanese encephalitis. J Indian Med Assoc. 2010;108(8):525-527
110. Basumatary LJ, et al. Clinical and radiological spectrum of Japanese encephalitis. J Neurol Sci. 2013;325(1-2):15-21.
111. Maschke M, et al. Update on neuroimaging in infectious central nervous system disease. Curr Opin Neurol. 2004;17(4):475-80.
112. Misra UK, Kalita J. Overview: Japanese encephalitis. Prog Neurobiol. 2010;91(2):108-20.
113. Kalita J, Misra UK. Comparison of CT scan and MRIfindings in the diagnosis of Japanese encephalitis. J Neurol Sci. 2000;174(1):3-8.
114. Kalita J, Misra UK. Markedly severe dystonia in Japanese encephalitis. Mov Disord. 2000;15(6):1168-72.
115. Handique SK, et al. Temporal lobe involvement in Japanese encephalitis: problems in differential diagnosis. AJNR Am J Neuroradiol. 2006;27(5):1027-31.
116. Toshio S, et al. Encephalitis associated with positive anti-GluR antibodies showing abnormal appearance in basal ganglia, pulvinar and gray matter on MRI-case report. Rinsho Shinkeigaku. 2011;51(3):192-6.
117. Kimura K, et al. Single-photon emission CTfindings in acute Japanese encephalitis. AJNR Am J Neuroradiol. 1997;18(3):465-9.
118. Kalita J, Das BK, Misra UK. SPECT studies of regional cerebral bloodflow in 8 patients with Japanese encephalitis in subacute and chronic stage. Acta Neurol Scand. 1999;99(4):213-8.
119. Misra UK, Kalita J. Anterior horn cells are also involved in Japanese encephalitis. Acta Neurol Scand. 1997;96(2):114-7.
120. Solomon T, Ooi MH, Mallewa M. Chapter 10 viral infections of lower motor neurons. Handb Clin Neurol. 2007;82:179-206.
121. Chung CC, et al. Acuteflaccid paralysis as an unusual presenting symptom of Japanese encephalitis: A case report and review of the literature. Infection. 2007;35(1):30-2.
122. Ding D, et al. Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg. 2007;77(3):528-33.
123. Ooi MH, et al. The epidemiology, clinical features, and long-term prognosis of Japanese encephalitis in Central Sarawak, Malaysia, 1997-2005. Clin Infect Dis. 2008;47(4):458-68.
124. Goto A. A long duration follow-up study of Japanese encephalitis. Folia Psychiatr Neurol Jpn. 1962;64:236-66.
125. Goto A. A long duration follow-up study of encephalitis Japonica. Folia Psychiatr Neurol Jpn. 1964;17:326-34.
126. Goto A. A long term follow-up study of encephalitis japonica-prognostic observations of 43 personal casesfifteen years after the onset. Seishin Shinkeigaku Zasshi. 1966;68(1):44-59.
127. Goto A. Sequelae of Japanese encephalitis from the viewpoint of neuropsychiatry. Shinkei Kenkyu No Shimpo. 1967;11(2):329-51.
128. Schneider RJ, et al. Clinical sequelae after Japanese encephalitis: A one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health. 1974;5(4):560-8.
129. Sarkari NB, et al. Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol. 2012;259(1):47-57.
130. Sarkari NB, et al. Japanese encephalitis (JE) part II: 14 years' follow-up of survivors. J Neurol. 2012;259(1):58-69.
131. Das S, Ghosh D, Basu A. Japanese encephalitis virus induce immuno-competency in neural stem/progenitor cells. PLoS One. 2009;4(12):e8134.
132. Das S, Basu A. Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J Neurochem. 2008;106(4):1624-36.
133. Desai A, et al. Co-existence of cerebral cysticercosis with Japanese encephalitis: A prognostic modulator. Epidemiol Infect. 1997;118(2):165-71.
134. Liu YF, Teng CL, Liu K. Cerebral cysticercosis as a factor aggravating Japanese B encephalitis. Chin Med J. 1957;75(12):1010-7.
135. Ravi V, et al. Association of Japanese encephalitis virus infection with Guillain-Barre syndrome in endemic areas of south India. Acta Neurol Scand. 1994;90(1):67-72.
136. Ankur Nandan V, et al. Acute transverse myelitis (ascending myelitis) as the initial manifestation of Japanese encephalitis: A rare presentation. Case Rep Infect Dis. 2013;2013:487659.
137. Verma R, et al. Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease. BMJ Case Rep. 2012. pii: bcr2012007094. doi: 10.1136/bcr-2012-007094.
138. Man BL., Fu YP. Thefirst case of mild encephalopathy with a reversible splenial lesion due to Japanese encephalitis virus infection. BMJ Case Rep. 2013. pii: bcr2013200988. doi: 10.1136/bcr-2013-200988
139. Chen WL, et al. A possible case of acute disseminated encephalomyelitis after Japanese encephalitis. Acta Neurol Taiwan. 2013;22(4):169-73.
140. Jia M, et al. Japanese encephalitis accompanied by cerebral venous sinus thrombosis: A case report. BMC Neurol. 2012;12:43.
141. Yun SI, Lee YM. Japanese encephalitis: The virus and vaccines. Hum Vaccin Immunother. 2014;10(2):263-79.
142. Haridas V, et al. Bispidine-amino acid conjugates act as a novel scaffold for the design of antivirals that block Japanese encephalitis virus replication. PLoS Negl Trop Dis. 2013;7(1):e2005.
143. Kumar R, et al. Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin Infect Dis. 2009;48(4):400-6.
144. Wu Z, et al. Broad-spectrum antiviral activity of RNA interference against four genotypes of Japanese encephalitis virus based on single microRNA polycistrons. PLoS One. 2011; 6(10):e26304.
145. Woodman DR, Williams JC. Effects of 2-deoxy-D-glucose and 3 deazauridine individually and in combination on the replication of Japanese B encephalitis virus. Antimicrob Agents Chemother. 1977;11(3):475-81.
146. Kaluza G, Scholtissek C, Rott R. Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose. J Gen Virol. 1972;14(3):251-9.
147. Klenk HD, Scholtissek C, Rott R. Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology. 1972;49(3):723-34.
148. Takegami T, et al. Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus. Antiviral Res. 1998;37(1):37-45.
149. Seniya C, et al. Antiviral potential of 4-hydroxypanduratin A, secondary metabolite of Fingerroot, Boesenbergia pandurata (Schult.), towards Japanese encephalitis virus NS2B/ NS3 protease. Bioinformation. 2013;9(1):54-60.
150. Appaiahgari MB, Vrati S. DNAzyme-mediated inhibition of Japanese encephalitis virus replication in mouse brain. Mol Ther. 2007;15(9):1593-9.
151. Lin RJ, et al. MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucleic Acids Res. 2013;41(5):3314-26.
152. Sebastian L, et al. Mycophenolic acid inhibits replication of Japanese encephalitis virus. Chemotherapy. 2011;57(1):56-61.
153. Shi Z, et al. Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model. Virol J. 2014;11:10.
154. Sebastian L, et al. Pentoxifylline inhibits replication of Japanese encephalitis virus: A comparative study with ribavirin. Int J Antimicrob Agents. 2009;33(2):168-73.
155. Ishag HZ, et al. Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein. Virus Res. 2013;171(1):89-96.
156. Anantpadma M, Stein DA, Vrati S. Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer. J Antimicrob Chemother. 2010;65(5):953-61.
157. Huggins JW, Robins RK, Canonico PG. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrob Agents Chemother. 1984;26(4):476-80.
158. Sebastian L, et al. Combination of N-methylisatin-beta-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro. Lett Appl Microbiol. 2012;55(3):234-9.
159. Sebastian L, et al. N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo. Virol J. 2008;5:64.
160. Anantpadma M, Vrati S. siRNA-mediated suppression of Japanese encephalitis virus replication in cultured cells and mice. J Antimicrob Chemother. 2012;67(2):444-51.
161. Xu K, et al. Suramin inhibits the in vitro expression of encephalitis B virus proteins NS3 and E. J Huazhong Univ Sci Technolog Med Sci. 2003;23(4):375-9.
162. Nazmi A, Dutta K, Basu A. Antiviral and neuroprotective role of octaguanidinium dendrimerconjugated morpholino oligomers in Japanese encephalitis. PLoS Negl Trop Dis. 2010; 4(11):e892.
163. Chen CJ, et al. Suppression of Japanese encephalitis virus infection by non-steroidal antiinflammatory drugs. J Gen Virol. 2002;83(Pt 8):1897-905.
164. Swarup V, et al. Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan. J Antimicrob Chemother. 2008;61(3):679-88.
165. Ye J, et al. Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis . J Infect Dis. 2014.
166. Sehgal N, et al. Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection. PLoS One. 2012;7(4):e35427.
167. Mishra MK, Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem. 2008;105(5):1582-95.
168. Mishra MK, et al. Antioxidant potential of minocycline in Japanese encephalitis virus infection in murine neuroblastoma cells: correlation with membranefluidity and cell death. Neurochem Int. 2009;54(7):464-70.
169. Yik SY, et al. Neuroprotective effects of minocycline on double-stranded RNA-induced neurotoxicity in cultured cortical neurons. Hong Kong Med J. 2012;18 Suppl 2:42-4.
170. Swarup V, et al. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother. 2007;51(9):3367-70.
171. Huang HN, et al. Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5. Biomaterials. 2011;32(28):6804-14.
172. Burke DS, Morill JC. Levels of interferon in the plasma and cerebrospinalfluid of patients with acute Japanese encephalitis. J Infect Dis. 1987;155(4):797-9.
173. Fensterl V, Sen GC. Interferons and viral infections. Biofactors. 2009;35(1):14-20.
174. Blanc M, et al. Host defense against viral infection involves interferon mediated downregulation of sterol biosynthesis. PLoS Biol. 2011;9(3):e1000598.
175. Zhou X, et al. Interferon induced IFIT family genes in host antiviral defense. Int J Biol Sci. 2013;9(2):200-8.
176. Houglum JE. Interferon: mechanisms of action and clinical value. Clin Pharm. 1983;2(1): 20-8.
177. Chang SJ, et al. Antiviral activity of Rheum palmatum methanol extract and chrysophanol against Japanese encephalitis virus . Arch Pharm Res. 2014.
178. Lin CW, et al. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents. 2008;32(4):355-9.
179. Taylor JL, Schoenherr C, Grossberg SE. Protection against Japanese encephalitis virus in mice and hamsters by treatment with carboxymethylacridanone, a potent interferon inducer. J Infect Dis. 1980;142(3):394-9.
180. Harinasuta C, Wasi C, Vithanomsat S. The effect of interferon on Japanese encephalitis virus in vitro. Southeast Asian J Trop Med Public Health. 1984;15(4):564-8.
181. Harinasuta C, Nimmanitya S, Titsyakorn U. The effect of interferon-alpha A on two cases of Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health. 1985;16(2): 332-6.
182. Solomon T, et al. Interferon alfa-2a in Japanese encephalitis: A randomised double-blind placebo-controlled trial. Lancet. 2003;361(9360):821-6.
183. Kajimura K, et al. Protective effect of astragali radix by oral administration against Japanese encephalitis virus infection in mice. Biol Pharm Bull. 1996;19(9):1166-9.
184. Kajimura K, et al. Protective effect of astragali radix by intraperitoneal injection against Japanese encephalitis virus infection in mice. Biol Pharm Bull. 1996;19(6):855-9.
185. Toda S, Shirataki Y. Inhibitory effects of astragali radix, a crude drug in Oriental medicines, on lipid peroxidation and protein oxidative modification by copper. J Ethnopharmacol. 1999;68(1-3):331-3.
186. Andoh T, et al. Effect of bafilomycin A1 on the growth of Japanese encephalitis virus in vero cells. J Neurovirol. 1998;4(6):627-31.
187. Johari J, et al. Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int J Mol Sci. 2012;13(12):16785-95.
188. Lee CJ, et al. Cholesterol effectively blocks entry offlavivirus. J Virol. 2008;82(13): 6470-80.
189. Dutta K, Ghosh D, Basu A. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. J Neuroimmune Pharmacol. 2009;4(3):328-37.
190. Ben-Nathan D, et al. Protection by dehydroepiandrosterone in mice infected with viral encephalitis. Arch Virol. 1991;120(3-4):263-71.
191. Chang CC, et al. Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection. J Gen Virol. 2005;86(Pt 9):2513-23.
192. Saxena SK, Mathur A, Srivastava RC. Inhibition of Japanese encephalitis virus infection by diethyldithiocarbamate is independent of its antioxidant potential. Antivir Chem Chemother. 2003;14(2):91-8.
193. Li C, et al. Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII. Antiviral Res. 2012;94(2):179-83.
194. Fan J, et al. Inhibition of Japanese encephalitis virus infection byflavivirus recombinant E protein domain III. Virol Sin. 2013;28(3):152-60.
195. Ishag HZ, et al. Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo. Arch Virol. 2013;158(2):349-58.
196. Chen J, et al. Unique heparan sulfate from shrimp s exhibits a strong inhibitory effect on infections by dengue virus and Japanese encephalitis virus. Biochem Biophys Res Commun. 2011;412(1):136-42.
197. Chang SJ, et al. Antiviral activity of Isatis indigotica extract and Its derived Indirubin against Japanese encephalitis virus. Evid Based Complement Alternat Med. 2012;2012:925830.
198. Chien YJ, et al. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Virology. 2008;379(1):143-51.
199. Wu SF, et al. Antiviral effects of an iminosugar derivative onflavivirus infections. J Virol. 2002;76(8):3596-604.
200. Lin YL, et al. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol. 1997;71(7):5227-35.
201. Li C, et al. A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo . Arch Virol. 2013.
202. Zu X, et al. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. Antiviral Res. 2014;104:7-14.
203. Lee E, et al. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephaliticflaviviruses. Antiviral Res. 2006;69(1):31-8.
204. Chiu YH, et al. Inhibition of Japanese encephalitis virus infection by the sulfated polysaccharide extracts from Ulva lactuca. Mar Biotechnol (NY). 2012;14(4):468-78.